> For the complete documentation index, see [llms.txt](https://www.parapathology.com/llms.txt). Markdown versions of documentation pages are available by appending `.md` to page URLs; this page is available as [Markdown](https://www.parapathology.com/systemic-pathology/gastrointestinal-pathology/colon-and-rectum/colon-colorectal-carcinoma.md).

# Colon Colorectal Carcinoma

## Molecular Pathology of Colorectal Cancer

Harada, Shuko MD; Morlote, Diana MD[Author Information ](https://journals.lww.com/anatomicpathology/Abstract/2020/01000/Molecular_Pathology_of_Colorectal_Cancer.4.aspx#)Advances In Anatomic Pathology: [January 2020 - Volume 27 - Issue 1 - p 20-26](https://journals.lww.com/anatomicpathology/toc/2020/01000)doi: 10.1097/PAP.0000000000000247

{% embed url="<https://journals.lww.com/anatomicpathology/Abstract/2020/01000/Molecular:Pathology:of:Colorectal:Cancer.4.aspx>" %}

## Approval of pembrolizumab (MSI- H/dMMR) and considerations for site-agnostic development of drugs in oncology

<https://www.ema.europa.eu/en/documents/presentation/presentation-session-5-approval-pembrolizumab-msi-h/dmmr-considerations-site-agnostic-development-drugs-oncology-steven-lemery_en.pdf>

## Template for Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of the Colon and Rectum

<https://documents.cap.org/protocols/cp-gilower-colonrectum-14biomarker-1201.pdf>

## NCCN Guidelines Colon Cancer

<https://www.nccn.org/professionals/physician_gls/pdf/colon.pdf>

## FDA Approves First-Line Immunotherapy for Patients with MSI-H/dMMR Metastatic Colorectal Cancer

<https://www.fda.gov/news-events/press-announcements/fda-approves-first-line-immunotherapy-patients-msi-hdmmr-metastatic-colorectal-cancer>

## Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population

[Lynch syndrome screening in colorectal cancer: results of a prospective 2-year regional programme validating the NICE diagnostics guidance pathway throughout a 5.2-million population](https://onlinelibrary.wiley.com/doi/10.1111/his.14390/full)

Comprehensive clinicopathologic, molecular, and immunologic characterization of colorectal carcinomas with loss of three intestinal markers, CDX2, SATB2, and KRT20

<https://link.springer.com/article/10.1007/s00428-021-03260-w>


---

# Agent Instructions
This documentation is published with GitBook. GitBook is the documentation platform designed so that both humans and AI agents can read, navigate, and reason over technical content effectively. Learn more at gitbook.com.

## Querying This Documentation
If you need additional information that is not directly available in this page, you can query the documentation dynamically by asking a question.

Perform an HTTP GET request on the current page URL with the `ask` query parameter, and the optional `goal` query parameter:

```
GET https://www.parapathology.com/systemic-pathology/gastrointestinal-pathology/colon-and-rectum/colon-colorectal-carcinoma.md?ask=<question>&goal=<endgoal>
```

`ask` is the immediate question: it should be specific, self-contained, and written in natural language.
`goal` is optional and describes the broader end goal you are ultimately trying to accomplish on behalf of the user. GitBook uses it to tailor the answer towards what is most useful for that goal.

The response will contain a direct answer to the question and relevant excerpts and sources from the documentation.

Use this mechanism when the answer is not explicitly present in the current page, you need clarification or additional context, or you want to retrieve related documentation sections.